The world’s first reloadable epinephrine auto-injector. Designed for reliability, affordability, and assurance of being prepared.
The anxiety of an expired pen. The high cost of replacement every year. The fear of not being ready. We knew there had to be a better, more reliable way to manage anaphylaxis.
Randomised simulated use with trainer devices; participants read instructions before tasks. PK performance was benchmarked against published literature for established auto-injectors. ZiBiPen is an investigational device and not yet authorised for sale
We started by listening. The features you see below are our answers to the real concerns raised by families and clinical experts, offering a more intuitive and reliable design that makes essential care more sustainable by eliminating unnecessary costs.
Features a protective safety sheath that locks after injection to prevent needle-stick injuries, and a clear viewing window, allowing you to visually check for discolouration that indicates expiration.
A cost-effective and sustainable design that allows the user to replace only the epinephrine cartridge annually, not the entire device.
An ergonomic, non-slip grip and a simple two-step activation process make the device straightforward and easy to handle in an emergency.
Offers various needle length selections to ensure effective Epinephrine delivery to the muscle, accommodating different body types.
Features a protective safety sheath that locks after injection to prevent needle-stick injuries, and a clear viewing window, allowing you to visually check for discolouration that indicates expiration.
A cost-effective and sustainable design that allows the user to replace only the epinephrine cartridge annually, not the entire device.
An ergonomic, non-slip grip and a simple two-step activation process make the device straightforward and easy to handle in an emergency.
Offers various needle length selections to ensure effective Epinephrine delivery to the muscle, accommodating different body types.
























We pursued global patents for our reloadable technology not just to protect an idea, but to protect our mission. This ensures we can bring a more affordable and sustainable option to families everywhere who live with the reality of anaphylaxis.
Stay updated on our milestones, partnerships and impact as we advance accessible emergency care across Africa through ZiBiPen.
We put ZiBiPen through extensive tests. It undergoes drop tests, extreme temperature and humidity testing, and lifecycle simulations to ensure it works in real-world emergencies. We use high-quality materials and strict quality control during manufacturing, so every device meets our high standards before it reaches you.
Yes, usability testing is a critical part of our development process and we have successfully conducted human clinical trials to validate the effectiveness and safety of the ZiBiPen.
1. It’s much more cost-effective because you only need to replace the drug cartridge instead of the entire device. This is particularly important for medications like epinephrine (adrenaline), which have a limited shelf life.
2. It’s environmentally friendly, as it minimises medical waste.
3. It provides peace of mind – you know you can always have a fresh dose of medication on hand without the expense and hassle of buying a whole new device.
We’ve conducted studies with different types of people of different ages using ZiBiPen under stressful conditions and everyone was able to use their ZiBiPen correctly even when they were stressed.
Want to support us? Email info@impulsebiomed.com and tell us your story of allergy and anaphylaxis. Your experiences help us advocate for the urgency of getting ZiBiPen to market faster!
Contact us for any inquiries or to learn more about our innovative ZiBiPen.
Address
160 Sir Lowry Road, Unit 403
The Armoury Building
Woodstock, Cape Town, 7925